Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process

Prions are believed to spontaneously convert from a native, monomeric highly helical form (called PrP(c)) to a largely β-sheet-rich, multimeric and insoluble aggregate (called PrP(sc)). Because of its large size and insolubility, biophysical characterization of PrP(sc) has been difficult, and there are several contradictory or incomplete models of the PrP(sc) structure. A β-sheet-rich, soluble intermediate, called PrP(β), exhibits many of the same features as PrP(sc) and can be generated using a combination of low pH and/or mild denaturing conditions. Studies of the PrP(c) to PrP(β) conversion process and of PrP(β) folding intermediates may provide insights into the structure of PrP(sc). Using a truncated, recombinant version of Syrian hamster PrP(β) (shPrP(90-232)), we used NMR spectroscopy, in combination with other biophysical techniques (circular dichroism, dynamic light scattering, electron microscopy, fluorescence spectroscopy, mass spectrometry, and proteinase K digestion), to characterize the pH-driven PrP(c) to PrP(β) conversion process in detail. Our results show that below pH 2.8 the protein oligomerizes and conversion to the β-rich structure is initiated. At pH 1.7 and above, the oligomeric protein can recover its native monomeric state through dialysis to pH 5.2. However, when conversion is completed at pH 1.0, the large oligomer "locks down" irreversibly into a stable, β-rich form. At pH values above 3.0, the protein is amenable to NMR investigation. Chemical shift perturbations, NOE, amide line width, and T(2) measurements implicate the putative "amylome motif" region, "NNQNNF" as the region most involved in the initial helix-to-β conversion phase. We also found that acid-induced PrP(β) oligomers could be converted to fibrils without the use of chaotropic denaturants. The latter finding represents one of the first examples wherein physiologically accessible conditions (i.e., only low pH) were used to achieve PrP conversion and fibril formation.     

Mutant PrP prevails over wild-type PrP in the brain of V210I and R208H genetic Creutzfeldt–Jakob disease patients

Creutzfeldt–Jakob disease (CJD) is a neurodegenerative disorder characterized by the deposition of the pathological conformer (PrP^CJD) of the host encoded cellular prion protein (PrP^C). In genetic CJD associated with V210I or R208H PrP substitutions, the pathogenic role of mutant residues is still poorly understood. To understand how V210I or R208H PrP mutations facilitate the development of the disease, we determined by mass spectrometry the quantitative ratio of mutant/wild-type PrP^CJD allotypes in brains from affected subjects. We found that the mutant PrP^CJD allotypes moderately exceeds of 2- or 3-fold the amount of the wild-type counterpart suggesting that these mutations mainly exert their pathogenic effect on the onset of the pathogenic cascade.     

抗牛PrP多肽单克隆抗体的制备及其在牛PrP 检测中的应用

为获得广谱抗哺乳类动物PrP单克隆抗体(monoclonal antibody, McAb), 用牛朊蛋白(prion protein, PrP)多肽(209~228 aa)与匙孔槭血蓝蛋白(keyhole limpet hemocyanin, KLH)偶联物免疫Balb/C小鼠. 经细胞融合和克隆后获得针对上述多肽的杂交瘤细胞株. 分别用Western blot和免疫组化(immunohistochemistry, IHC)的方法检测这些McAbs与重组人(human, Hu)、牛(bovine, Bo)、仓鼠(hamster, Ha)PrP蛋白、牛脑组织中的正常朊蛋白(cellular PrP, PrPc)和致病性朊蛋白(scrapie of prion, PrPSc)的反应性. 本文为制备高效价抗PrP McAb提供了一个简单、易行的方法. 制备的抗体可用于研究哺乳类PrP生物学特性, 检测可传播性海绵样脑病, 特别是对牛海绵样脑病的诊断具有重要意义.     

The octarepeat region of hamster PrP （PrP51-91） enhances the formation of microtubule and antagonize Cu^2＋-induced microtubule-disrupting activity

Prion protein （PrP） is considered to associate with microtubule and its major component, tubulin. In the present study, octarepeat region of PrP （PrP51-91） was expressed in prokaryotic-expressing system. Using GST pull-down assay and co-immunoprecipitation, the molecular interaction between PrP51-91 and tubulin was observed. Our data also demonstrated that PrP51-91 could efficiently stimulate microtubule assembly in vitro, indicating a potential effect of PrP on microtubule dynamics. Moreover, PrP51-91 was confirmed to be able to antagonize Cu^2＋-induced microtubule-disrupting activity in vivo, partially protecting against Cu^2＋- intoxication to culture cells and stabilize cellular microtubule structure. The association of the octarepeat region of PrP with tubufin may further provide insight into the biological function of PrP in the neurons.     

A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V

Gerstmann-Str?ussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val(129) being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a approximately 7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148, Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the approximately 7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Str?ussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a approximately 7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.     

PrP的胞内运输与朊病毒病

朊病毒病,即传染性海绵状脑病（transmissible spongiform encephalopathies,TSEs）,是一类致死性的神经退行性疾病,存在散发性、感染性和遗传性3种形式。在朊病毒病的病理过程中,细胞正常朊蛋白PrPc（cellular PrP）转化为异常构象的PrP^Sc（scrapie PrP）是至关重要的,但是朊病毒的增殖如何导致神经元凋亡仍不清楚。PrPc的胞内运输在朊病毒病中发挥重要作用,朊病毒感染后PrP^C转化为PrP^Sc,及遗传性朊病毒病中PrP突变可能影响PrP的生物合成、亚细胞定位及转运过程,通过干扰PrP^C的正常功能或产生毒性中间体而导致神经系统病变。现对近年来关于PrP胞内运输在朊病毒病中的作用进行综述。     

金黄地鼠PrP基因组织特异性表达的研究

金黄地鼠是研究动物传染性海绵状脑病的理想模型动物之一,我们利用实时荧光定量RT-PCR技术,构建标准重组质粒制备标准曲线,对中枢神经系统的4个不同部位及外周6个组织提取总RNA,反转录后进行PrP基因表达的定量.结果发现,脑的四个检测部位都呈现高的表达量;在外周器官中,淋巴结的表达量和全脑相当,脾脏、心脏、肝脏和肺脏呈现中等程度的表达,肾脏的表达量最低.本研究的结果对于探讨朊蛋白的基本功能和不同组织在传染性海绵状病理发生中的作用,提供了基础数据.     

金黄地鼠PrP基因组织特异性表达的研究

金黄地鼠是研究动物传染性海绵状脑病的理想模型动物之一,我们利用实时荧光定量RT-PCR技术,构建标准重组质粒制备标准曲线,对中枢神经系统的4个不同部位及外周6个组织提取总RNA,反转录后进行PrP基因表达的定量.结果发现,脑的四个检测部位都呈现高的表达量;在外周器官中,淋巴结的表达量和全脑相当,脾脏、心脏、肝脏和肺脏呈现中等程度的表达,肾脏的表达量最低.本研究的结果对于探讨朊蛋白的基本功能和不同组织在传染性海绵状病理发生中的作用,提供了基础数据.     

靶向PrP及Aβ的治疗性抗体研究进展

朊病毒病与阿尔茨海默病具有蛋白质异常折叠的共同特征, 患者均有痴呆的症状, 但前者具有传染性, 而后者没有. 这引起人们的研究兴趣, 从不同角度开展了二者的比较研究. 近年来, 靶向其关键蛋白PrP和Aβ的免疫治疗研究进展很快. 本文结合实际研究工作, 着眼于治疗性抗体的疾病靶向性和构象特异性等主要特征, 综述了针对PrP和Aβ治疗性抗体研究中的新视点和新策略, 以期为探索这两种疾病的共同机制及治疗方法提供参考.     

蛋白激酶CK2与PrP蛋白的体外相互作用研究

为了探讨蛋白激酶CK2与PrP是否存在分子间相互作用,利用RT-PCR方法从人源细胞系SH-SY5Y cDNA中分别扩增出蛋白激酶CK2a和CK2β基因,并在E coli中表达了融合蛋白HIS-CK2α和GST-HISCK2β.利用pU-doWn及免疫共沉淀实验检测PrP与CK2的分子间相互作用.结果显示,重组PrP可与CK2α出现特异性结合,但不与CK2β发生反应.天然状态下脑组织中的CK2与PrPc也发生相互作用.PrP与CK2α亚基相互作用的区域位于PrP的C-端90～231位氨基酸.本研究从分子水平上提供了人重组和天然CK2和PrP蛋白相互作用的实验依据,为深入探讨CK2与朊蛋白作用的生物学意义和在朊病毒病发病过程中的作用提供了科学线索.     

人PrP基因体外诱导细胞凋亡的初步研究

朊蛋白为可传播性海绵样脑病的感染因子。将编码朊病毒白的ＰｒＰ标准及突变ＤＮＡ序列分别连接到真核表达载体ｐｃＤＮＡ３．１中,并分别转入中国仓鼠卵巢细胞（ＣＨＯ）。以过ＲＴ－ＰＣＲ、ＲＮＡｄｏｔ ｂｌｏｔ、Ｗｅｓｔｅｒｎ ｂｌｏｔ鉴定证实,得到了稳定表达人标准（ＣＨＯｓ）和终止密码突变ＰｒＰ基因（ＣＨＯｍ）的细胞系。对此细胞系进一步研究发现,带有标准人ＰｒＰ序列的ＣＨＯ细胞系的生长速度比其它对照细胞系     

两种PrP截短型多肽的神经毒性

PrP^106-126和PrP^118-135分别对应于人PrP^c序列中106～126残基和118～135残基,两个肽段在试验中具备prpsc的部分病理特症,因此PrP^106-126和PrP^118-135就成为了研究PrP^Sc神经细胞毒性致病机制的合适的模型。     

一种新的PrP无细胞构象转化系统的建立

PrP细胞外构象转化系统已经被一些实验室用于朊病毒的研究,但在反应体系中往往需要使用放射性同位素。为了建立一种安全方便的PrP无细胞构象转化系统用于TSE发病机制的研究,通过PCR方法获得仓鼠PrP(HaPrP)全长基因,克隆至原核表达载体pQE30,在大肠杆菌中表达并纯化出分子量为27kD HaPrP蛋白,Western blot证实可与PrP特异性单克隆抗体反应。将纯化蛋白在体外标记生物素(Biotin-7-NHs),与纯化的scrapie 263K毒株仓鼠感染脑组织PrP^Se蛋白共同孵育4天后,经蛋白酶K消化,Western blot检测,证明存在一条抵抗蛋白酶K消化的、被亲和素特异性识别的条带,其分子量约为20kD。这表明HaPrP^sen可以被转化为HaPrP^res。实验表明,可以利用原核系统取代真核系统表达PrP,并用生物素标记取代^35S标记纯化蛋白,建立一个更加安全方便的无细胞构象转化系统,用于朊病毒的研究。     

Neurotoxic species in prion disease: a role for PrP isoforms?

Prion diseases such as bovine spongiform encephalopathy in cattle and Creutzfeldt–Jakob disease in humans are associated with the misfolding and accumulation of an abnormal conformation of the host-encoded prion protein (PrP). Despite intensive research efforts conducted on PrP, the toxic agent involved in neurodegeneration is as yet unidentified. Several potential candidates have been proposed, each of which may be relevant to subsets of the broad array of prion diseases. In this study, we review current knowledge on neurotoxic PrP species, including the importance of a central hydrophobic domain for mediating neurotoxicty.     

多肽PrP106—126对培养神经细胞朊蛋白基因表达的影响

神经细胞是传染性海绵状脑病（transmissible spongiform encephalopathies,TSEs）的重要靶细胞,PrP106-126是研究TSEs致病机理的理想工具,对PrP106-126作用的培养神经细胞模型进行研究,有利于了解朊蛋白的功能和探讨TSEs的分子致病机制。本研究利用PrP106-126构建了大脑皮质和小脑颗粒神经元作用模型,对神经细胞的存活和朊蛋白基因的表达进行了研究。结果表明：PrP106-126作用于培养神经细胞导致其存活率的显著下降;大脑皮质神经元经PrP106-126处理后,与SCR处理组和对照组相比,基因表达的量明显下降,处理后的小脑颗粒神经元也有类似的情况出现,两者之间下降的幅度和时间不同。我们的研究结果为研究朊蛋白在TSEs发生中的作用和深入了解TSE的分子致病机制提供了基础数据。     

多肽PrP106-126对培养神经细胞朊蛋白基因表达的影响

神经细胞是传染性海绵状脑病(transmissible spongiform encephalopathies, TSEs)的重要靶细胞,PrP106-126是研究TSEs致病机理的理想工具,对PrP106-126作用的培养神经细胞模型进行研究,有利于了解朊蛋白的功能和探讨TSEs的分子致病机制.本研究利用PrP106-126构建了大脑皮质和小脑颗粒神经元作用模型,对神经细胞的存活和朊蛋白基因的表达进行了研究.结果表明PrP106-126作用于培养神经细胞导致其存活率的显著下降;大脑皮质神经元经PrP 106-126处理后,与SCR处理组和对照组相比,基因表达的量明显下降,处理后的小脑颗粒神经元也有类似的情况出现,两者之间下降的幅度和时间不同.我们的研究结果为研究朊蛋白在TSEs发生中的作用和深入了解TSE的分子致病机制提供了基础数据.     

细胞浆中PrP蛋白的表达及其细胞毒性作用的研究

为了探讨在胞浆中表达的PrP的理化特征以及对细胞活性的影响,我们构建了胞浆型PrP(CytoPrP)真核表达质粒,瞬时转染人神经母细胞瘤SH-SY5Y细胞,通过蛋白酶敏感性实验检测CytoPrP及其蛋白酶抗性,利用MTT和Trypan Blue细胞计数检测CytoPrP的细胞毒性作用.结果显示,CytoPrP在胞浆内的存在受蛋白酶抑制剂的控制;与野生型PrP相比,CytoPrP具有相对较强的蛋白酶K(PK)抗性.MTT和细胞计数实验均显示,Cyto-PrP的存在可诱导明显的细胞毒性效应,而CytoPrP的细胞毒性作用受蛋白酶抑制剂含量的影响,呈剂量依赖关系.上述结果为研究CytoPrP在朊病毒病的发病机制中的意义提供了一定的科学数据.     

The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance

We report the results of solid state nuclear magnetic resonance (NMR) measurements on amyloid fibrils formed by the full-length prion protein PrP (residues 23?231, Syrian hamster sequence). Measurements of intermolecular 13C?13C dipole?dipole couplings in selectively carbonyl-labeled samples indicate that β-sheets in these fibrils have an in-register parallel structure, as previously observed in amyloid fibrils associated with Alzheimer’s disease and type 2 diabetes and in yeast prion fibrils. Two-dimensional 13C?13C and 15N?13C solid state NMR spectra of a uniformly 15N- and 13C-labeled sample indicate that a relatively small fraction of the full sequence, localized to the C-terminal end, forms the structurally ordered, immobilized core. Although unique site-specific assignments of the solid state NMR signals cannot be obtained from these spectra, analysis with a Monte Carlo/simulated annealing algorithm suggests that the core is comprised primarily of residues in the 173?224 range. These results are consistent with earlier electron paramagnetic resonance studies of fibrils formed by residues 90?231 of the human PrP sequence, formed under somewhat different conditions [Cobb, N. J., Sonnichsen, F. D., McHaourab, H., and Surewicz, W. K. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 18946?18951], suggesting that an in-register parallel β-sheet structure formed by the C-terminal end may be a general feature of PrP fibrils prepared in vitro.